Alpha Biopharma picks up Series A funding
Alpha Biopharma Inc, a biopharmaceutical company for the Chinese and global markets, has closed $37 million in its $65 million Series A funding round. Qiming Venture Partners led the round with participation from other investors that included TF Fund and the LYZZ Healthcare Venture Fund. In conjunction with the funding, Dr. William Hu, managing partner of Qiming Venture Partners, will join Alpha Biopharma's board of directors.
19 June 2018•1 min read
